ENLV
Enlivex Therapeutics Ltd

6,649
Loading...
Loading...
News
all
press releases
Enlivex Therapeutics' Stable Financial Outlook
Enlivex Therapeutics (ENLV) has released an update. Enlivex Therapeutics Ltd., a company working on therapeutic candidates, has reportedly maintain...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / March 22, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Unusual Machines Inc. (NYSE American:UMAC) on the RedChip Small...
Accesswire·1y ago
News Placeholder
Enlivex Therapeutics Ltd at Jefferies Healthcare Conference Transcript
Check out Jefferies Group Stock Picks » Download GuruFolio Report of Jefferies Group (Updated on 02/28/2024)Related Stocks: FRA:1BT...
GuruFocus·2y ago
News Placeholder
Enlivex Therapeutics Ltd at Robert W Baird Global Healthcare Conference Transcript
Related Stocks: FRA:1BT...
GuruFocus·2y ago
News Placeholder
Enlivex Therapeutics Ltd at H C Wainwright Global Investment Conference Transcript
Related Stocks: FRA:1BT...
GuruFocus·2y ago
News Placeholder
Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
NES-ZIONA, ISRAEL / ACCESSWIRE / February 26, 2024 / As we age, our knees start aching for reasons we can't quite pinpoint. Medicines temporarily decrease pain but don't help with the inflammatory...
Accesswire·2y ago
News Placeholder
Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals
NES-ZIONA, ISRAEL / ACCESSWIRE / February 21, 2024 / Mike Williams made a name for himself making difficult endzone catches for the Tampa Bay Buccaneers. Around the corner from the stadium where he...
Accesswire·2y ago
News Placeholder
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
Second study of Allocetra in knee osteoarthritis, following the on-going Phase I/II trial in pre-surgery, end-stage osteoarthritis, that is continuing to enroll patients Nes-Ziona, Israel...
Globe Newswire·2y ago
News Placeholder
Enlivex Therapeutics receives IMOH regulatory authorization
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Enlivex Therapeutics (NASDAQ:ENLV) vs. G1 Therapeutics (NASDAQ:GTHX) Financial Analysis
Enlivex Therapeutics (NASDAQ:ENLV Get Free Report) and G1 Therapeutics (NASDAQ:GTHX Get Free Report) are both small-cap medical companies, but which is the better stock? We will...
Zolmax·2y ago

Latest ENLV News

View

Advertisement. Remove ads.

Advertisement. Remove ads.